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Purpose or Objective: The development of MR-guided HDR 
brachytherapy has gained an increasing interest for delivering 
a high tumor dose safely. However, the update rate of MR-
based needle localization is inherently low and the required 
image interpretation is hampered by signal voids arising from 
blood vessels or calcifications, which limits the precision of 
the needle steering.  
This study aims to assess the potential of fiber optic sensing 
for real-time needle tracking during MR-guided intervention. 
For this, the MR compatibility of a fiber optic tracking system 
and its accuracy are evaluated. 
 
Material and Methods: Fiber optic tracking device: The 
device consists of a flexible stylet with three optic fibers 
embedded along its length, a broadband light source, a 
spectrum analyzer and a PC with Labview application. Along 
each fiber, Bragg gratings are evenly spaced at 20 mm 
intervals. To reconstruct the shape of a needle, the stylet is 
inserted inside the lumen of the needle. This set-up placed in 
the 1.5T MR-scanner provides real-time measurement of the 
needle profile, without adverse imaging artefacts since no 
ferromagnetic material is involved. 
MRI-acquisition protocol: 3D MR-images were acquired with a 
1.5T MR-scanner, using a 3D Spectral Presaturation with 
Inversion Recovery (SPIR) sequence (TR=2.9ms, TE=1.44ms, 
voxel size= 1.2×1.45×1mm^3, FOV=60×250×250mm^3). 
Experimental evaluation: The two following experiments 
were conducted: 
1. A needle was placed inside the MR-bore and its 
shape was imposed by a specially designed plastic 
mold with different known paths (see Fig. 1a). For 
path 1, 2 and 3, the shape of the needle was 
measured by fiber optic tracking during MR-imaging 
along 4 orientations (i.e 0°, 90°, 180°, 270°), by 
rotating the needle along its longitudinal axis. 
2. Four plastic catheters were introduced in an agar 
phantom. The corresponding catheter shapes were 
measured with fiber optic sensing during 
simultaneous MR imaging (see Fig. 1d, phantom 
shifted out of scanner for photograph). The MR-
based needle shape stemmed from a segmentation 
step followed by a polynomial fitting (order 5). A 
rigid registration of the obtained MR-based needle 
model and the fiber optic tracking was then 
performed. 
Assessment of the fiber optic tracking: The fiber optic 
needle tracking accuracy was quantified by calculating the 
Euclidian distances between: the gold-standard shapes and 
fiber optic based measurements (Experiment #1); MR- and 
fiber optic based measurements (Experiment #2). 
 
Results: For all tested needle shapes, the maximum absolute 
difference between the fiber optic based and the gold-
standard values was lower than 0.9mm (Experiment #1, Fig. 
1b and 1c). Over the 4 tested catheters, the maximal 
absolute difference between MR- and fiber optic based 
measurements was lower than 0.9mm (Experiment #2, Fig. 
1e, 1f and 1g). 
 
Conclusion: This study demonstrates that the employed fiber 
optic tracking device is able to monitor the needle bending 
during MR-imaging with an accuracy and update rate eligible 
for MR-guided intervention. 
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Purpose or Objective: MOSkin detectors coupled to a trans-
rectal ultrasound (TRUS) probe were used to perform in vivo 
dosimetry (IVD) on the rectal wall surface during US-based 
HDR prostate brachytherapy (BT). The system, called dual 
purpose probe (DPP), has proven to be an accurate tool to 
measure in vivo the integral dose, however discrepancies 
between planned and measured doses from each single 
catheter can be much higher than the overall discrepancies. 
In this work, three HDR prostate BT sessions were studied to 
find a possible distance and angle dependence correction 
function (CF) to be applied in real time to each single 
catheter, and data with and without the application of the 
obtained CF were compared. 
 
Material and Methods: The DPP can be sketched as follows: 
four MOSkin dosimeters are firmly attached to TRUS rectal 
probe and are connected to a multichannel reader which 
provides measurements of the voltage shifts (proportional to 
the dose) in the MOSkin sensitive layer caused by radiation 
exposure. A dedicated software plots and records the 
measured dose with each MOSkin as a function of time, 
allowing the identification of the dose contribution of each 
single catheter in real time. Based on the treatment plan 
data (i.e. planned source strength, dwell times and positions) 
a software was implemented in the Matlab environment to 
compute the dose contribution to the MOSkin from each 
catheter based on TG-43 algorithm. The software reports also 
the weighted average distance of source to MOSkin for each 
catheter and the resulting weighted polar angles. IVD data 
were acquired on three patients treated between June and 
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October 2015 and retrospectively analysed, providing 141 
dose measurements for all the MOSkins. Measured and 
calculated contributions by each single catheter were 
quantified separately. Discrepancies were plotted depending 
on weighted average polar angles and distances between 
MOSkins and source, and a linearly fitting CF was calculated. 
 
Results: A correction function CF linearly depending on the 
weighted average distance and polar angle of the catheter 
from the dosimeter was obtained (R=0.35, showing a 
significant correlation). The results showed an increase in 
sensitivity of MOSkins at higher distances (i.e., due to 
radiation softening) and at wider polar angles (i.e., due to 
increased radiation contamination by the presence of the 
TRUS probe). The percentage dose discrepancy between 
calculated and measured dose contribution from each single 
catheter with and without the application of obtained CF 
resulted in 1.3±13.1% and 1.2±7.7% (k=1), respectively (figure 
1). 
 
 
 
Conclusion: The use of the CF significantly reduces 
percentage discrepancy between planned and measured dose 
per single catheter. Implementation of the CF to correct 
MOSkin readings online is a further step towards accurate and 
reliable real time IVD in prostate BT performed with the DPP. 
Based on the real time measured dose discrepancy, the next 
step will be defining an action protocol to use the acquired 
information online. 
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Purpose or Objective: Rotating shield brachytherapy (RSBT) 
is an intensity modulated high dose rate (HDR) BT treatment 
technique, where radiation sources are surrounded by 
catheters containing rotating shields that direct radiation 
towards the tumour and away from healthy tissues. RSBT for 
HDR requires sources with lower energies than Ir-192, such as 
Gd-153 and Se-75, due to shield thickness constraints. The 
distinct features of shield angle, catheter material and 
source isotope require the development of a specific Monte 
Carlo (MC)-based treatment planning and optimization 
system. 
 
Material and Methods: An MC based dose calculation engine 
for RSBT has been developed and coupled with a column-
generation optimizer. At every iteration of the optimization 
loop, the column-generation process solves a pricing problem 
to determine the best dwell position and shield angle 
combination to add to the treatment plan, resulting in the 
best possible plan with the shortest treatment time. 
As a source model, the microSelectron-v2 source geometry 
was selected and placed inside a cylindrical platinum shield 
with a diameter of 1.8 mm and 3.0 mm for interstitial and 
intracavitary cases, respectively. An emission window 
coinciding with the active core of the source was created by 
removing half (180º) of the wall of the shield. 
For an interstitial prostate case, RSBT plans were generated 
only using Gd-153 as a source due to the extreme limitations 
on shield size in interstitial catheters. For the intracavitary 
GYN case, both Gd-153 and Se-75 plans were generated. All 
RSBT plans were compared with conventional HDR BT. Only 
the original dwell positions used in conventional BT were 
sampled to create the RSBT plans. 
 
Results: RSBT plans resulted in a considerable reduction in 
both rectum and bladder doses without sacrificing target 
coverage for the prostate case. With 95% of the PTV volume 
receiving over 15 Gy, only 40% of the rectum volume received 
more than 2 Gy for the Gd-153 RSBT case,as opposed to 85% 
for the unshielded Ir-192 conventional plan. 
 
 
For the GYN patient, the median rectum dose was 2.4 Gy, 3.2 
Gy and 3.45 Gy for Gd-153 RSBT, Se-75 RSBT and unshielded 
Ir-192, respectively, with an identical target coverage. The 
Gd-153 case was also able to reduce the dose to the bladder 
by 41%. 
 
Conclusion: The development of the first MC-based TPS 
devoted to RSBT has been successfully accomplished. For the 
prostate case, a significant dosimetric improvement was 
achieved over conventional BT using Gd-153 with optimized 
shield angles. For the GYN case, the improvement was 
diminished by the central position of the conventional BT 
dwell positions within the target volume. RSBT allows the 
placement of dwell positions much closer to normal tissue, 
which will yield superior dose distributions when properly 
optimized. RSBT will decrease normal tissue toxicity and 
allow for tailoring treatments to each individual patient by 
treating all parts of the tumour without over-irradiation of 
large regions of normal tissues. 
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Purpose or Objective: Acute dysphagia is a frequently 
observed toxicity during concurrent chemo-radiation (CRT) or 
high-dose radiotherapy (RT) for lung cancer. This toxicity can 
lead to hospitalizations, treatment interruptions and 
